Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Results available

Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft Investigational Device Exemption (IDE) Study

ClinicalTrials.gov ID: NCT02949297

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT02949297. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 8:45 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A prospective clinical evaluation of the effectiveness of the Ovation Alto Abdominal Stent Graft System when used in the treatment of subjects with abdominal aortic aneurysm (AAA).

Study identification

NCT ID
NCT02949297
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Endologix
Industry
Enrollment
75 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 30, 2017 (Actual)
Primary completion
Mar 6, 2019 (Actual)
Completion
Mar 6, 2019 (Actual)
Last update posted
Dec 22, 2021

2017 – 2019

United States locations

U.S. sites
13
U.S. states
12
U.S. cities
13
Facility City State ZIP Site status
Abrazo Arizona Heart Hospital Phoenix Arizona 85016 —
VA San Diego San Diego California 92161 —
Northwestern University Chicago Illinois 60611 —
Carle Foundation Hospital Urbana Illinois 61801 —
Massachusetts General Hospital Boston Massachusetts 02114 —
New Mexico Heart Institute Albuquerque New Mexico 87102 —
University at Buffalo Clinical Translational Research Center/Kaleida Health/GVI/Buffalo General Medical Center Buffalo New York 14203 —
Mission Hospital Asheville North Carolina 28801 —
Cleveland Clinic Foundation Cleveland Ohio 44195 —
North Central Heart Sioux Falls South Dakota 57108 —
Wellmont CVA Heart Institute Kingsport Tennessee 37660 —
Baylor St. Luke's Medical Center Houston Texas 77030 —
Swedish Heart and Vascular Research Seattle Washington 98122 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02949297, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 22, 2021 · Synced Nov 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.